In contrast to cardiorenal syndrome ... should the enhancement of cardiovascular death initiated by kidney disease be termed 'renocardiac syndrome'? As the kidney is the primary regulator of ...

Thank you again for joining us. This is Nihar Desai from the Yale School of Medicine, for the Medscape InDiscussion Cardiorenal Metabolic Syndrome Podcast.

can we prevent the development of the visceral insulin resistance-adiposity syndrome and metabolic cardiorenal disease? Diabetes prevention or delay has been seen with tirzepatide. The future ...

In the preceding sections, we identified many unanswered questions related to the metabolic syndrome. Many are unresolved fundamental issues that raise considerable doubt about the construct itself.

"One is more aggressive and mainly affects the liver, while the other is entwined in the cardio-renal-metabolic syndrome." The researchers used genetic tests to identify 27 new genetic variants ...

The FDA’s Center for Biologics Evaluation and Research (CBER) granted Breakthrough Device Designation for the SCD in cardiorenal syndrome with LVAD in September 2023. “Oftentimes patients with ...

E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, ...

05, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases ...